Pages that link to "Q45920564"
Jump to navigation
Jump to search
The following pages link to Thomas O'Dorisio (Q45920564):
Displaying 50 items.
- Elevated pancreatic polypeptide levels in pancreatic neuroendocrine tumors and diabetes mellitus: causation or association? (Q26849797) (← links)
- Medical management of metastatic medullary thyroid cancer (Q27005897) (← links)
- Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells (Q28142976) (← links)
- Two-career families: published data and personal reflections (Q30886395) (← links)
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors. (Q33438326) (← links)
- Pancreastatin predicts survival in neuroendocrine tumors (Q34016884) (← links)
- 90Y-edotreotide for metastatic carcinoid refractory to octreotide (Q34101554) (← links)
- Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide (Q34428697) (← links)
- Uterine prostaglandin E secretion and uterine blood flow in the pregnant rabbit (Q34472726) (← links)
- RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner (Q34518263) (← links)
- Studies of the mechanism of oliguria in a model of unilateral acute renal failure. (Q34518759) (← links)
- Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment (Q34546925) (← links)
- Radiolabeled peptides in diagnosis and tumor imaging: clinical overview (Q34608866) (← links)
- Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: Nine standard SEER registries, 1975–2006 (Q34610406) (← links)
- A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors (Q34624881) (← links)
- Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors (Q34680094) (← links)
- Limitations of somatostatin scintigraphy in primary small bowel neuroendocrine tumors (Q34732644) (← links)
- Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial (Q34965132) (← links)
- Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution (Q35018379) (← links)
- A prospective trial on the effect of body mass index and sex on plasma octreotide levels in patients undergoing long-term octreotide LAR therapy (Q35200992) (← links)
- Neuroendocrine tumors arising in Meckel's diverticula: frequency of advanced disease warrants aggressive management (Q35626153) (← links)
- Recommended guidelines for the treatment of cancer treatment-induced diarrhea (Q35836588) (← links)
- Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine Tumors (Q36330126) (← links)
- Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy? (Q36395882) (← links)
- Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy (Q36534909) (← links)
- Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study (Q36565634) (← links)
- Minimally invasive parathyroidectomy and preoperative MIBI scans: correlation of gland weight and preoperative PTH. (Q36960771) (← links)
- Somatic alterations of CDKN1B are associated with small bowel neuroendocrine tumors. (Q37075351) (← links)
- Phase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptors (Q37122608) (← links)
- When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation? (Q37496864) (← links)
- Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors (Q37504159) (← links)
- Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors (Q37694773) (← links)
- NANETS consensus guidelines for the diagnosis of neuroendocrine tumor (Q37776135) (← links)
- The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum (Q37776137) (← links)
- Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators (Q37811562) (← links)
- Neuroendocrine tumors: current recommendations for diagnosis and surgical management (Q37846930) (← links)
- Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution (Q37918477) (← links)
- The value of preoperative imaging in small bowel neuroendocrine tumors (Q38071233) (← links)
- Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach (Q38394095) (← links)
- A 25-Year Experience of Gastroenteropancreatic Neuroendocrine Tumors and Somatostatin (Congeners) Analogs: From Symptom Control to Antineoplastic Therapy (Q38573046) (← links)
- Extra-adrenal paraganglioma and pulmonary chondroma: a case report and review of the literature. (Q39462856) (← links)
- Treatment of resistant acromegaly with a long-acting somatostatin analogue (SMS 201-995). (Q39541087) (← links)
- Is GIP a glucagon cell constituent? (Q39644709) (← links)
- Effects of pancreatic polypeptide and vasoactive intestinal polypeptide on rat ileal and colonic water and electrolyte transportin vivo (Q40244547) (← links)
- Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors. (Q40467865) (← links)
- Intraoperative Localization of Intestinal Arteriovenous Malformation (Q40673381) (← links)
- Mild chronic watery diarrhea-hypokalemia syndrome associated with pancreatic islet cell hyperplasia. Elevated plasma and tissue levels of gastric inhibitory polypeptide and successful management with nicotinic acid (Q41043560) (← links)
- Gastric Inhibitory Polypeptide (GIP) and Insulin Release in Duodenal Ulcer Patients* (Q41210787) (← links)
- Characterization of the in vivo and in vitro inhibition of gastrin secretion from gastrinoma by a somatostatin analogue (SMS 201-995). (Q41342976) (← links)
- Gastric response to severe head injury. (Q41592779) (← links)